Brief: Galapagos Announces Board Decision To Initiate Wind-Down Of Cell Therapy Activities
05/01/2026 22:14
Galapagos NV GLPG.AS: GALAPAGOS ANNOUNCES BOARD DECISION TO INITIATE WIND-DOWN OF CELL THERAPY ACTIVITIES GALAPAGOS NV - WIND-DOWN IMPACTS ABOUT 365 EMPLOYEES GALAPAGOS NV - CLOSURE OF SITES IN LEIDEN, BASEL, PRINCETON, PITTSBURGH, SHANGHAI Source text: ID:nGNX1KNcHd Further company coverage: GLPG.AS
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Brief: Lakefront Receives Transparency Notification From Bank Of America
Belgium's Galapagos Q1 revenue falls 91% but returns to profit
Brief: Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition
Brief: Galapagos Announces Nomination Of Gino Santini To Its Board Of Directors